Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses some counseling points pharmacists can provide to patients on COPD medications.
Bruce Berger, PhD, president of Berger Consulting LLC, discusses the behavioral patterns that contribute to a patient’s propensity to be more or less adherent to their medications.
Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about some current trends in state protocols related to pharmacists' abilities to dispense smoking cessation products.
Chris Hatwig, MS, FASHP of Apexus discusses how split billing software helps to keep contract pharmacies organized with respect to 340B requirements.
Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research, discusses the biggest factors that play a role in determining the likelihood that a patient will remain adherent to medications during care transitions.
A generic equivalent to Bristol-Myers Squibb’s entecavir (Baraclude) hepatitis B treatment has been approved by the FDA.
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about information pharmacists should give patients on high-dose basal insulin.
In the recent past, bipolar disorder has been classified as the most costly mental illness.
A list of the most debilitating diseases a patient may face over his or her lifetime was recently curated by Healthcare Business and Technology.
Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses strategies pharmacists can use to support asthma management.